Jaguar Health (JAGX) Interest Expenses (2014 - 2026)
Jaguar Health's (JAGX) quarterly Interest Expenses came in at $1.7 million in Q1 2026, up 215.72% year-on-year from $547000.0 in Q1 2025, and up 3221.15% on a QoQ basis from $52000.0 in Q4 2025.
Jaguar Health (JAGX) Interest Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Interest Expenses data on file, last reported at $1.7 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 215.72% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 215.72% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, down 98.05% from the prior year.
- Interest Expenses for Q1 2026 stood at $1.7 million, up from $52000.0 in the prior quarter.
- Over the last five years, Interest Expenses for JAGX reached as high as $12.7 million in Q4 2022 and fell as low as -$110000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $3.0 million across 5 years, with a median of $2.1 million in 2025.
- Across the five-year window, Interest Expenses surged 511.46% in 2022 and plunged 101.81% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $12.7 million in 2022, then sank by 52.13% to $6.1 million in 2023, then plunged by 101.81% to -$110000.0 in 2024, then soared by 147.27% to $52000.0 in 2025, then surged by 3221.15% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $1.7 million in Q1 2026, $52000.0 in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | 100,000.00 |
| 3 | BeOne Medicines | 473.37 Bn | 468.58 Bn | 1.35 Bn | 32.89 Mn |
| 4 | Vertex Pharmaceuticals | 123.58 Bn | 116.33 Bn | 2.59 Bn | 420.30 Mn |
| 5 | Regeneron Pharmaceuticals | 71.54 Bn | 62.78 Bn | 3.31 Bn | 28.30 Mn |
| 6 | Belite Bio | 62.17 Bn | 62.17 Bn | - | 13.20 Mn |
| 7 | Argenx Se | 54.63 Bn | 49.44 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.11 Bn | 35.10 Bn | 959.66 Mn | 69.29 Mn |
| 9 | Revolution Medicines | 36.17 Bn | 36.17 Bn | - | 1.17 Bn |
| 10 | Jaguar Health | 523,524.81 | -9.54 Mn | 19.11 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 52,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 547,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 6.08 Mn |
| Dec 31, 2023 | 6.08 Mn |